Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
BioRestorative Therapies, Inc. develops cell-based therapeutic products primarily using adult stem cells for regenerative medicine. Its core programs target chronic lower back pain via BRTX-100, an autologous mesenchymal stem cell therapy for disc and spine conditions, and metabolic disorders through the ThermoStem platform using brown adipose-derived stem cells. The company also operates a biocosmeceuticals segment offering cell-based aesthetic products. It focuses on minimally invasive treatments with proprietary technology and clinical-grade manufacturing.
This description was generated via AI from an annual report. Updated about 1 year ago.